Regado Biosciences Inc (RGDO) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 95 transactions totaling $85.8M, demonstrating a bullish sentiment with $83.4M in net insider flow. The most recent transaction on Oct 28, 2014 involved a sale of 941,252 shares valued at $1.0M.
No significant insider buying has been recorded for RGDO in the recent period.
No significant insider selling has been recorded for RGDO in the recent period.
Based on recent SEC filings, insider sentiment for RGDO is bullish with an Insider Alignment Score of 99/100 and a net flow of $83.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Regado Biosciences Inc (RGDO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading RGDO stock, having executed 95 transactions in the past 90 days. The most active insider is Anton Gopka (Executive), who has made 2 transactions totaling $15.5M.
Get notified when executives and directors at RGDO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 28, 2014 | A. Kierlin Robert | Executive | Sale | 941,252 | $1.10 | $1.0M | Large |
| Oct 27, 2014 | A. Kierlin Robert | Executive | Sale | 18,748 | $1.08 | $20.2K | |
| Oct 24, 2014 | A. Kierlin Robert | Executive | Sale | 10,000 | $1.06 | $10.6K | |
| Oct 24, 2014 | A. Kierlin Robert | Executive | Sale | 100,000 | $1.10 | $110.0K | |
| Apr 16, 2014 | A. Kierlin Robert | Executive | Purchase | 575,000 | $6.00 | $3.5M | Large |
| Mar 21, 2014 | L. P/il Bvf Partners | Executive | Other | 915,345 | $N/A | $0 | |
| Mar 21, 2014 | L. P/il Bvf Partners | Executive | Other | 526,436 | $N/A | $0 | |
| Feb 20, 2014 | Jefferson Clark B. | Executive | Exercise | 5,447 | $4.51 | $24.6K | |
| Feb 20, 2014 | Jefferson Clark B. | Executive | Exercise | 3,341 | $4.51 | $15.1K | |
| Feb 20, 2014 | Jefferson Clark B. | Executive | Exercise | 4,491 | $0.17 | $763 | |
| Feb 20, 2014 | Jefferson Clark B. | Executive | Exercise | 2,095 | $3.34 | $7.0K | |
| Feb 5, 2014 | A. Kierlin Robert | Executive | Purchase | 400,000 | $5.00 | $2.0M | Large |
| Aug 27, 2013 | Vi, L.p. Domain Partners | Executive | Conversion | 225,913 | $N/A | $0 | |
| Aug 27, 2013 | Vi, L.p. Domain Partners | Executive | Conversion | 394,969 | $N/A | $0 | |
| Aug 27, 2013 | Vi, L.p. Domain Partners | Executive | Conversion | 270,568 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $84.6M | 98.6% |
Sale(S) | 4 | $1.2M | 1.4% |
Exercise (Options)(X) | 4 | $47.4K | 0.1% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 68 | $0 | 0.0% |
Insiders at Regado Biosciences Inc are accumulating shares at an accelerated pace. With 18 insiders making 95 transactions totaling $84.6M in purchases versus $1.2M in sales, the net buying activity of $83.4M signals strong executive confidence. Anton Gopka (Executive) leads the buying activity with $15.5M in transactions across all time.